Please join Autobahn Labs and the Penn Center for Innovation (PCI) for an info session and lunch. Come learn how Autobahn identifies high-value proposals and leverages industry resources to supercharge academic drug discovery. Following a short presentation on Autobahn's model, attendees will have the opportunity to network with members of the Autobahn team, PCI, and other drug hunters in the UPenn community.

We encourage all faculty and trainees engaged in life science research to attend.

Autobahn Labs is a venture-backed accelerator that develops novel drugs by partnering with academics. We invest in the best ideas in academic biotech and take a high throughput approach to de-risking projects. Autobahn works closely with PIs at 7 university partners and has funded 12 programs spanning a breadth of disease areas and modalities.

Model Highlights:

• Partner with academics on drug discovery
• Transform early-stage research projects into de-risked development candidates
• Initial investment up to $1M with R&D to de-risk projects at all stages
• Maximize value for stakeholders and accelerate drug development
• Commitment to providing valuable feedback on any project

Register to attend the event here.

For more information, please contact:

Jared Feldman, Associate, Business Development (jared@autobahn-labs.com)

Sangeeta Bafna, Associate Director, Technology Licensing (sbafna@upenn.edu)